UV GERMI SA (ALUVI.PA) Stock Fundamental Analysis

EPA:ALUVI • FR0011898584

2.97 EUR
-0.03 (-1%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Taking everything into account, ALUVI scores 4 out of 10 in our fundamental rating. ALUVI was compared to 109 industry peers in the Machinery industry. ALUVI has an excellent financial health rating, but there are some minor concerns on its profitability. ALUVI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ALUVI had positive earnings in the past year.
  • Of the past 5 years ALUVI 4 years were profitable.
  • In the past 5 years ALUVI always reported negative operating cash flow.
ALUVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALUVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 500K -500K

1.2 Ratios

  • With a decent Return On Assets value of 5.27%, ALUVI is doing good in the industry, outperforming 69.91% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 5.80%, ALUVI is in line with its industry, outperforming 46.02% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.15%, ALUVI is doing worse than 69.91% of the companies in the same industry.
Industry RankSector Rank
ROA 5.27%
ROE 5.8%
ROIC 3.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALUVI.PA Yearly ROA, ROE, ROICALUVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2023 2024 0 5 -5 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.75%, ALUVI is in the better half of the industry, outperforming 76.11% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ALUVI has grown nicely.
  • With a Operating Margin value of 5.61%, ALUVI perfoms like the industry average, outperforming 46.02% of the companies in the same industry.
  • The Gross Margin of ALUVI (51.20%) is better than 67.26% of its industry peers.
  • ALUVI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.61%
PM (TTM) 7.75%
GM 51.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.03%
GM growth 3Y3.79%
GM growth 5Y5.14%
ALUVI.PA Yearly Profit, Operating, Gross MarginsALUVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ALUVI has about the same amount of shares outstanding.
  • ALUVI has more shares outstanding than it did 5 years ago.
  • ALUVI has a better debt/assets ratio than last year.
ALUVI.PA Yearly Shares OutstandingALUVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 1M 2M 3M
ALUVI.PA Yearly Total Debt VS Total AssetsALUVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • An Altman-Z score of 6.37 indicates that ALUVI is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ALUVI (6.37) is better than 94.69% of its industry peers.
  • ALUVI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • ALUVI's Debt to Equity ratio of 0.00 is amongst the best of the industry. ALUVI outperforms 95.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.37
ROIC/WACCN/A
WACCN/A
ALUVI.PA Yearly LT Debt VS Equity VS FCFALUVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

  • ALUVI has a Current Ratio of 7.88. This indicates that ALUVI is financially healthy and has no problem in meeting its short term obligations.
  • ALUVI's Current ratio of 7.88 is amongst the best of the industry. ALUVI outperforms 98.23% of its industry peers.
  • ALUVI has a Quick Ratio of 5.51. This indicates that ALUVI is financially healthy and has no problem in meeting its short term obligations.
  • ALUVI has a Quick ratio of 5.51. This is amongst the best in the industry. ALUVI outperforms 98.23% of its industry peers.
Industry RankSector Rank
Current Ratio 7.88
Quick Ratio 5.51
ALUVI.PA Yearly Current Assets VS Current LiabilitesALUVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 200.00% over the past year.
  • Measured over the past years, ALUVI shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.53% on average per year.
  • ALUVI shows a decrease in Revenue. In the last year, the revenue decreased by -9.66%.
  • ALUVI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.64% yearly.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y42.53%
EPS Q2Q%-26.67%
Revenue 1Y (TTM)-9.66%
Revenue growth 3Y10.44%
Revenue growth 5Y6.64%
Sales Q2Q%-22.1%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALUVI.PA Yearly Revenue VS EstimatesALUVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALUVI.PA Yearly EPS VS EstimatesALUVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.50, ALUVI is valued correctly.
  • Based on the Price/Earnings ratio, ALUVI is valued a bit cheaper than the industry average as 73.45% of the companies are valued more expensively.
  • ALUVI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.5
Fwd PE N/A
ALUVI.PA Price Earnings VS Forward Price EarningsALUVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALUVI.PA Per share dataALUVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.39
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALUVI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UV GERMI SA

EPA:ALUVI (2/13/2026, 7:00:00 PM)

2.97

-0.03 (-1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-06
Earnings (Next)N/A
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners26.64%
Ins Owner ChangeN/A
Market Cap9.59M
Revenue(TTM)7.48M
Net Income(TTM)580.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.5
Fwd PE N/A
P/S 1.28
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)0.18
EY6.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.32
BVpS3.02
TBVpS2.64
PEG (NY)N/A
PEG (5Y)0.39
Graham Number3.49
Profitability
Industry RankSector Rank
ROA 5.27%
ROE 5.8%
ROCE 4.29%
ROIC 3.15%
ROICexc 3.15%
ROICexgc 3.6%
OM 5.61%
PM (TTM) 7.75%
GM 51.2%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.03%
GM growth 3Y3.79%
GM growth 5Y5.14%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.88
Quick Ratio 5.51
Altman-Z 6.37
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y42.53%
EPS Q2Q%-26.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.66%
Revenue growth 3Y10.44%
Revenue growth 5Y6.64%
Sales Q2Q%-22.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

UV GERMI SA / ALUVI.PA FAQ

What is the fundamental rating for ALUVI stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALUVI.PA.


Can you provide the valuation status for UV GERMI SA?

ChartMill assigns a valuation rating of 1 / 10 to UV GERMI SA (ALUVI.PA). This can be considered as Overvalued.


What is the profitability of ALUVI stock?

UV GERMI SA (ALUVI.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of UV GERMI SA (ALUVI.PA) stock?

The Price/Earnings (PE) ratio for UV GERMI SA (ALUVI.PA) is 16.5 and the Price/Book (PB) ratio is 0.98.